missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ADAM30 (aa 494-613) Control Fragment Recombinant Protein
missing translation for 'orderingAttributeHoverText'
Quantity:
100 μL
missing translation for 'unitSize'
100µL
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (61%), Rat (61%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-55288 (PA5-55288. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This gene is testis-specific and contains a polymorphic region, resulting in isoforms with varying numbers of C-terminal repeats.
Especificaciones
Especificaciones
| Accession Number | Q9UKF2 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 11085 |
| Name | Human ADAM30 (aa 494-613) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | a disintegrin and metalloproteinase; a disintegrin and metalloproteinase domain 30; ADAM; ADAM 30; ADAM metallopeptidase domain 30; ADAM30; ADAMs; Disintegrin and metalloproteinase domain-containing protein 30; metalloendopeptidases; svph4; UNQ2509/PRO5997 |
| Common Name | ADAM30 |
| Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido